Itau Unibanco Holding S.A. Novavax Inc Transaction History

Itau Unibanco Holding S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $82,336 - $344,366	-4,524 Reduced 91.32%	430 $8,000
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $171,459 - $355,820	4,726 Added 2072.81%	4,954 $255,000
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $6,862 - $11,116	51 Added 28.81%	228 $35,000
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $889 - $1,352	5 Added 2.91%	177 $37,000
Q2 2021 Aug 17, 2021	BUY	$121.0 - $257.67 $20,812 - $44,319	172 New	172 $37,000

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.